Research moves closer to identifying CTE in living patients
Key Points:
- New research published in The Journal of the American Medical Association reveals a blood test that could detect advanced stages of chronic traumatic encephalopathy (CTE) in living patients, a condition previously diagnosable only post-mortem.
- The study, conducted by Boston University and Banner Health, identified a specific protein marker in the blood of former football players who were later confirmed to have CTE through autopsy.
- While the test currently applies only to advanced CTE and is based on a small sample size, researchers are optimistic that future validation could lead to highly accurate detection and open pathways for clinical trials and treatment.
- The ultimate objective is to develop a test capable of detecting any stage of CTE in living patients, enabling players to make informed decisions about continuing their careers and allowing leagues to consider medical clearance policies.
- The advancement of such a diagnostic tool could also stimulate research into potential treatments for CTE, fundamentally impacting player health management and safety protocols in football.